Anpario (LSE:ANP), the animal health and nutrition specialist, has delivered a first half in which Earnings rose considerably faster than revenue, although it has flagged a softer start to the second half linked to conflict involving Iran. In interim results published on 9 September 2026, the company reported a 7% rise in sales and a 30% increase in diluted adjusted earnings per share, alongside a higher interim dividend.
What the company does
Anpario develops and sells natural feed additives designed to support animal health, nutrition and biosecurity. Its products are used by livestock producers and feed manufacturers in poultry, pig, ruminant and aquaculture markets, and are sold in many countries through its own subsidiaries and distributors. The company positions its range as alternatives that can help producers reduce reliance on antibiotics and improve productivity.
Latest developments
According to the interim results for the six months to 30 June 2026, sales rose 7% to £24.3 million. Adjusted EBITDA increased 22% to £5.0 million and profit before tax rose 11% to £3.8 million. Diluted adjusted Earnings Per Share climbed 30% to 20.77p, outpacing growth in both sales and pre-tax profit.
The board said it remains confident in the group's prospects, pointing to Business development initiatives, a solid order pipeline and its geographic diversity. It also noted that the conflict involving Iran had softened the start to the second half, with the company citing challenges in Asia. Anpario hosted an investor presentation through the Investor Meet Company platform on the day of the results.
Financial and dividend picture
Shareholder returns have been a consistent feature. The Interim Dividend was raised by 6% to 3.8p per share. Between June and July 2026 the company issued a series of announcements on transactions in its own shares, and on 27 July it announced the completion of its share buyback programme. Several notifications of major shareholdings followed, the most recent on 28 October 2026.
The scale of Buybacks and the rising dividend indicate that the company has been generating enough cash to return Capital to investors while continuing to invest in its operations.
Sector and index context
Anpario (LSE:ANP) is one of the specialist agricultural and life sciences businesses in the FTSE AIM All Share Index. Demand for feed additives is linked to global protein production, which tends to be resilient over time but can be affected by disease outbreaks, Commodity prices and trade disruption. Regulatory pressure to cut antibiotic use in livestock farming has supported interest in natural alternatives, an area in which Anpario competes with much larger international groups.
Key risks
Geopolitical events are a clear risk, as the company's comments on the Iran conflict show, particularly for sales into the Middle East and Asia. Anpario is also exposed to currency movements, raw material and freight costs, livestock disease outbreaks and competition. Sad news came in August 2026 when the company announced the death of a non-executive director, and board composition will be one area to follow.
What to watch next
Investors will watch for a trading update covering the second half, which should show how far the Iran-related disruption has affected sales and whether the solid order pipeline has translated into revenue. Full-year results will reveal the final dividend and any new capital return plans following the completed buyback. Updates on board appointments and on progress in key regional markets will also be of interest.






Please wait processing your request...